Genmab (GMAB)
(Delayed Data from NSDQ)
$23.53 USD
-0.18 (-0.76%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $23.52 -0.01 (-0.04%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth B Momentum C VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 34% (86 out of 250)Zacks Sector Rank
Top 19% (3 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.28 | 1.37 | 9.99 |
Current Quarter Estimate | 0.31 | 2.59 | 63.00 |
Year Ago Quarter Estimate | 0.47 | -4.98 | 52.25 |
Next Quarter Estimate | 0.37 | 3.37 | 66.00 |
Next Year Estimate | 1.50 | 23.17 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 7.63 | 17.40 | 15.67 |
Next Year | 18.11 | 10.10 | 11.34 |
Last 5 Years | NA | 4.00 | 8.10 |
Next 5 Years | 26.10 | 21.20 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 19.45 | -7.28 |
Price/Book (MRQ) | 3.48 | 1.97 |
Price/Cash Flow (MRFY) | 18.98 | 15.50 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 29.06% | -101.26% |
Return on Equity (TTM) | 17.48% | -60.58% |
Debt to Equity (MRQ) | NA | 8.58 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.